+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Humira Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 91 Pages
  • May 2025
  • Region: Global
  • Prof Research
  • ID: 5596692
Description Jump to:
Humira (adalimumab) is a TNF inhibitor used for autoimmune diseases, including rheumatoid arthritis (RA), psoriatic arthritis (PsA), Crohn’s disease (CD), ulcerative colitis (UC), and ankylosing spondylitis, affecting approximately 80 million RA patients and 0.3-0.5% of populations in North America and Northern Europe with IBD. The market is driven by rising autoimmune disease prevalence, with IBD incidence doubling in Asia and Africa over 20 years, and biosimilar adoption, reducing prices by 10-80% in Europe. High-efficacy formulations, 70% reimbursement in OECD countries, and an aging population (1 billion over 60 in 2020, projected to reach 2.1 billion by 2050) boost demand. The global Humira market is estimated at USD 3.8-7.0 billion in 2025, with a CAGR of (-3)%-1% through 2030 due to biosimilar competition.

Regional Market Trends

  • North America: The U.S. leads with high RA and IBD prevalence, while Canada focuses on biosimilar adoption.
  • Europe: Germany, France, and the UK drive growth with robust reimbursement and biosimilars.
  • Asia Pacific: China and India see rising demand due to increasing IBD incidence, with Japan emphasizing biologics.
  • Rest of the World: Brazil expands public health access, while the Middle East addresses autoimmune care.

Application Analysis

  • Rheumatoid Arthritis (RA): Expected growth of (-2)%-2%, driven by high usage (40% of patients). Trends focus on biosimilars.
  • Psoriatic Arthritis (PsA): Projected growth of (-3)%-1%, linked to autoimmune prevalence. Advances emphasize high-concentration formulations.
  • Crohn’s Disease (CD): Anticipated growth of (-2)%-2%, with 30% patient usage. Trends highlight biosimilar access.
  • Ulcerative Colitis (UC): Expected growth of (-3)%-1%, suited for IBD. Developments prioritize patient compliance.
  • Ankylosing Spondylitis: Expected growth of (-3)%-1%, covering niche indications. Trends focus on generics.
  • Others: Expected growth of (-4)%-0%, including psoriasis. Trends highlight combination therapies.

Type Analysis

  • Branded: Expected growth of (-5)%-(-1)%, impacted by biosimilars. Trends focus on high-concentration formulations.
  • Biosimilar: Projected growth of 0%-4%, favored for cost-effectiveness. Advances emphasize market expansion.

Key Market Players

  • AbbVie: Pioneers Humira for autoimmune diseases.
  • Amgen: Develops adalimumab biosimilars.
  • Sandoz: Offers cost-effective biosimilars.
  • Pfizer: Provides biosimilars for affordability.
  • Samsung Bioepis: Focuses on biosimilar formulations.

Porter’s Five Forces Analysis

  • Threat of New Entrants: Moderate, due to high R&D costs, but biosimilars lower barriers.
  • Threat of Substitutes: Moderate, with other TNF inhibitors competing, but Humira remains a standard.
  • Bargaining Power of Buyers: High, as biosimilars increase price competition.
  • Bargaining Power of Suppliers: Low, with multiple biologics manufacturers.
  • Competitive Rivalry: High, with biosimilar manufacturers competing on price and access.

Market Opportunities and Challenges

Opportunities:

  • Addressing RA, affecting 80 million people globally.
  • Managing IBD, with 0.3-0.5% prevalence in high-income regions.
  • Leveraging biosimilars, reducing prices by 10-80%.
  • Utilizing 70% reimbursement coverage in OECD countries.
  • Supporting an aging population, with 2% RA prevalence.
  • Expanding high-concentration formulations, improving compliance by 25%.

Challenges:

  • Price erosion due to biosimilars.
  • Competition from other TNF inhibitors.
  • Regulatory delays for biosimilar approvals.
  • High costs of branded Humira limiting access.
  • Patient adherence issues with long-term therapies.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Humira Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Humira Market in North America (2020-2030)
8.1 Humira Market Size
8.2 Humira Market by End Use
8.3 Competition by Players/Suppliers
8.4 Humira Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Humira Market in South America (2020-2030)
9.1 Humira Market Size
9.2 Humira Market by End Use
9.3 Competition by Players/Suppliers
9.4 Humira Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Humira Market in Asia & Pacific (2020-2030)
10.1 Humira Market Size
10.2 Humira Market by End Use
10.3 Competition by Players/Suppliers
10.4 Humira Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Humira Market in Europe (2020-2030)
11.1 Humira Market Size
11.2 Humira Market by End Use
11.3 Competition by Players/Suppliers
11.4 Humira Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Humira Market in MEA (2020-2030)
12.1 Humira Market Size
12.2 Humira Market by End Use
12.3 Competition by Players/Suppliers
12.4 Humira Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Humira Market (2020-2025)
13.1 Humira Market Size
13.2 Humira Market by End Use
13.3 Competition by Players/Suppliers
13.4 Humira Market Size by Type
Chapter 14 Global Humira Market Forecast (2025-2030)
14.1 Humira Market Size Forecast
14.2 Humira Application Forecast
14.3 Competition by Players/Suppliers
14.4 Humira Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 AbbVie
15.1.1 Company Profile
15.1.2 Main Business and Humira Information
15.1.3 SWOT Analysis of AbbVie
15.1.4 AbbVie Humira Revenue, Gross Margin and Market Share (2020-2025)
15.2 Amgen
15.2.1 Company Profile
15.2.2 Main Business and Humira Information
15.2.3 SWOT Analysis of Amgen
15.2.4 Amgen Humira Revenue, Gross Margin and Market Share (2020-2025)
15.3 Coherus Biosciences
15.3.1 Company Profile
15.3.2 Main Business and Humira Information
15.3.3 SWOT Analysis of Coherus Biosciences
15.3.4 Coherus Biosciences Humira Revenue, Gross Margin and Market Share (2020-2025)
15.4 Sandoz
15.4.1 Company Profile
15.4.2 Main Business and Humira Information
15.4.3 SWOT Analysis of Sandoz
15.4.4 Sandoz Humira Revenue, Gross Margin and Market Share (2020-2025)
15.5 Pfizer
15.5.1 Company Profile
15.5.2 Main Business and Humira Information
15.5.3 SWOT Analysis of Pfizer
15.5.4 Pfizer Humira Revenue, Gross Margin and Market Share (2020-2025)
15.6 Boehringer Ingelheim
15.6.1 Company Profile
15.6.2 Main Business and Humira Information
15.6.3 SWOT Analysis of Boehringer Ingelheim
15.6.4 Boehringer Ingelheim Humira Revenue, Gross Margin and Market Share (2020-2025)
15.7 Fresenius Kabi
15.7.1 Company Profile
15.7.2 Main Business and Humira Information
15.7.3 SWOT Analysis of Fresenius Kabi
15.7.4 Fresenius Kabi Humira Revenue, Gross Margin and Market Share (2020-2025)
15.8 Samsung Bioepis
15.8.1 Company Profile
15.8.2 Main Business and Humira Information
15.8.3 SWOT Analysis of Samsung Bioepis
15.8.4 Samsung Bioepis Humira Revenue, Gross Margin and Market Share (2020-2025)
15.9 Fujifilm Kyowa Kirin Biologics
15.9.1 Company Profile
15.9.2 Main Business and Humira Information
15.9.3 SWOT Analysis of Fujifilm Kyowa Kirin Biologics
15.9.4 Fujifilm Kyowa Kirin Biologics Humira Revenue, Gross Margin and Market Share (2020-2025)
15.10 Celltrion
15.10.1 Company Profile
15.10.2 Main Business and Humira Information
15.10.3 SWOT Analysis of Celltrion
15.10.4 Celltrion Humira Revenue, Gross Margin and Market Share (2020-2025)
15.11 Alvotech
15.11.1 Company Profile
15.11.2 Main Business and Humira Information
15.11.3 SWOT Analysis of Alvotech
15.11.4 Alvotech Humira Revenue, Gross Margin and Market Share (2020-2025)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Humira Report
Table Data Sources of Humira Report
Table Major Assumptions of Humira Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Humira Picture
Table Humira Classification
Table Humira Applications
Table Drivers of Humira Market
Table Restraints of Humira Market
Table Opportunities of Humira Market
Table Threats of Humira Market
Table COVID-19 Impact For Humira Market
Table Raw Materials Suppliers
Table Different Production Methods of Humira
Table Cost Structure Analysis of Humira
Table Key End Users
Table Latest News of Humira Market
Table Merger and Acquisition
Table Planned/Future Project of Humira Market
Table Policy of Humira Market
Table 2020-2030 North America Humira Market Size
Figure 2020-2030 North America Humira Market Size and CAGR
Table 2020-2030 North America Humira Market Size by Application
Table 2020-2025 North America Humira Key Players Revenue
Table 2020-2025 North America Humira Key Players Market Share
Table 2020-2030 North America Humira Market Size by Type
Table 2020-2030 United States Humira Market Size
Table 2020-2030 Canada Humira Market Size
Table 2020-2030 Mexico Humira Market Size
Table 2020-2030 South America Humira Market Size
Figure 2020-2030 South America Humira Market Size and CAGR
Table 2020-2030 South America Humira Market Size by Application
Table 2020-2025 South America Humira Key Players Revenue
Table 2020-2025 South America Humira Key Players Market Share
Table 2020-2030 South America Humira Market Size by Type
Table 2020-2030 Brazil Humira Market Size
Table 2020-2030 Argentina Humira Market Size
Table 2020-2030 Chile Humira Market Size
Table 2020-2030 Peru Humira Market Size
Table 2020-2030 Asia & Pacific Humira Market Size
Figure 2020-2030 Asia & Pacific Humira Market Size and CAGR
Table 2020-2030 Asia & Pacific Humira Market Size by Application
Table 2020-2025 Asia & Pacific Humira Key Players Revenue
Table 2020-2025 Asia & Pacific Humira Key Players Market Share
Table 2020-2030 Asia & Pacific Humira Market Size by Type
Table 2020-2030 China Humira Market Size
Table 2020-2030 India Humira Market Size
Table 2020-2030 Japan Humira Market Size
Table 2020-2030 South Korea Humira Market Size
Table 2020-2030 Southeast Asia Humira Market Size
Table 2020-2030 Australia Humira Market Size
Table 2020-2030 Europe Humira Market Size
Figure 2020-2030 Europe Humira Market Size and CAGR
Table 2020-2030 Europe Humira Market Size by Application
Table 2020-2025 Europe Humira Key Players Revenue
Table 2020-2025 Europe Humira Key Players Market Share
Table 2020-2030 Europe Humira Market Size by Type
Table 2020-2030 Germany Humira Market Size
Table 2020-2030 France Humira Market Size
Table 2020-2030 United Kingdom Humira Market Size
Table 2020-2030 Italy Humira Market Size
Table 2020-2030 Spain Humira Market Size
Table 2020-2030 Belgium Humira Market Size
Table 2020-2030 Netherlands Humira Market Size
Table 2020-2030 Austria Humira Market Size
Table 2020-2030 Poland Humira Market Size
Table 2020-2030 Russia Humira Market Size
Table 2020-2030 MEA Humira Market Size
Figure 2020-2030 MEA Humira Market Size and CAGR
Table 2020-2030 MEA Humira Market Size by Application
Table 2020-2025 MEA Humira Key Players Revenue
Table 2020-2025 MEA Humira Key Players Market Share
Table 2020-2030 MEA Humira Market Size by Type
Table 2020-2030 Egypt Humira Market Size
Table 2020-2030 Israel Humira Market Size
Table 2020-2030 South Africa Humira Market Size
Table 2020-2030 Gulf Cooperation Council Countries Humira Market Size
Table 2020-2030 Turkey Humira Market Size
Table 2020-2025 Global Humira Market Size by Region
Table 2020-2025 Global Humira Market Size Share by Region
Table 2020-2025 Global Humira Market Size by Application
Table 2020-2025 Global Humira Market Share by Application
Table 2020-2025 Global Humira Key Vendors Revenue
Figure 2020-2025 Global Humira Market Size and Growth Rate
Table 2020-2025 Global Humira Key Vendors Market Share
Table 2020-2025 Global Humira Market Size by Type
Table 2020-2025 Global Humira Market Share by Type
Table 2025-2030 Global Humira Market Size by Region
Table 2025-2030 Global Humira Market Size Share by Region
Table 2025-2030 Global Humira Market Size by Application
Table 2025-2030 Global Humira Market Share by Application
Table 2025-2030 Global Humira Key Vendors Revenue
Figure 2025-2030 Global Humira Market Size and Growth Rate
Table 2025-2030 Global Humira Key Vendors Market Share
Table 2025-2030 Global Humira Market Size by Type
Table 2025-2030 Humira Global Market Share by Type

Companies Mentioned

  • AbbVie
  • Amgen
  • Coherus Biosciences
  • Sandoz
  • Pfizer
  • Boehringer Ingelheim
  • Fresenius Kabi
  • Samsung Bioepis
  • Fujifilm Kyowa Kirin Biologics
  • Celltrion
  • Alvotech

Related Topics

Related Reports

Humira Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Humira Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 184 Pages
  • Global
From
Humira Market Size, Share & Trends Analysis Report by Product (Branded, Biosimilar), Application (Rheumatoid Arthritis, Psoriatic Arthritis, Crohn's Disease), Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

Humira Market Size, Share & Trends Analysis Report by Product (Branded, Biosimilar), Application (Rheumatoid Arthritis, Psoriatic Arthritis, Crohn's Disease), Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Humira Biosimilar Global Market Report 2025 - Product Image

Humira Biosimilar Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Humira Drug Market Report 2025 - Product Image

Humira Drug Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Adalimumab (Humira) Biosimilars Pipeline Review - Product Image

Adalimumab (Humira) Biosimilars Pipeline Review

  • Report
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.